Allied Biotech (ROCO:1780) Operating Cash Flow per Share : NT$1.43 (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Operating Cash Flow per Share?

Allied Biotech's operating cash flow per share for the six months ended in Dec. 2023 was NT$0.66. Allied Biotech's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1.43.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Allied Biotech was -16.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 32.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Allied Biotech's Operating Cash Flow per Share or its related term are showing as below:

ROCO:1780' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -47.1 Med: 2.4 Max: 135.8
Current: 32

During the past 13 years, Allied Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 135.80% per year. The lowest was -47.10% per year. And the median was 2.40% per year.

ROCO:1780's 3-Year OCF Growth Rate is ranked better than
78.14% of 805 companies
in the Drug Manufacturers industry
Industry Median: 7.6 vs ROCO:1780: 32.00

Allied Biotech Operating Cash Flow per Share Historical Data

The historical data trend for Allied Biotech's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Operating Cash Flow per Share Chart

Allied Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.22

0.62

0.76

1.72

1.43

Allied Biotech Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.06	0.58	1.13	0.77	0.66

Competitive Comparison of Allied Biotech's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Allied Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allied Biotech's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Allied Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Allied Biotech's Price-to-Operating-Cash-Flow falls into.

Allied Biotech Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Allied Biotech's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	137.617	/	95.973
	=	1.43

Allied Biotech's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	63.819	/	96.119
	=	0.66

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$1.43

Allied Biotech Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Allied Biotech (ROCO:1780) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN

Website

http://www.altratene.com

Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech (ROCO:1780) Headlines

No Headlines